Form 4: Chimerix Director Martha J Demski Reports Stock Option Grant

Director Martha J Demski of Chimerix, Inc. reports the acquisition of stock options.

Summary

• On June 20, 2024, Martha J Demski, a director of Chimerix, Inc., acquired stock options.
• The options grant her the right to buy 60,000 shares of Chimerix common stock at an exercise price of $0.89 per share.
• The options vest in 12 equal monthly installments from the grant date, with full vesting occurring by the earlier of June 19, 2025, or the date of the company's 2024 annual stockholder meeting.
• Following the transaction, Demski directly owns 60,000 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to stock option grants, which is generally neutral. The grant itself can be seen as a positive sign of incentivizing management, but it's not a major event.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company's success.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, particularly in the biotechnology industry, to incentivize performance and align interests with shareholders.

Stakeholder Impact

• The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
• The grant incentivizes the director, potentially leading to better company performance.

Key Dates